"Vx Pharma offers professional services to biopharma startups looking to enter the clinical development process. We partner with our clients to complete their early phase research programs (safety to proof-of-concept) at-risk in exchange for select geographic licensing rights. We also offer business advisory services to biopharma startups looking to raise money or refine their business strategy to optimize their chances of success."

During the past decade, VX Pharma conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "VX Pharma" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "VX Pharma" are "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "HIV-1-infection" (1 trials), "Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "VX Pharma" in a lesser frequency.

Most popular intervention types in "VX Pharma" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ad26.COV2.S" (1 trials), "Empagliflozin" (1 trials), "Failing ARV Regimen" (1 trials) and "JNJ-53718678" (1 trials). Other intervention names were less common.

The vast majority of trials in "VX Pharma" are 5 trials for "All" genders.

Currently, there are NaN active trials in "VX Pharma". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in VX Pharma, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in VX Pharma, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".